| 注册
首页|期刊导航|中国妇幼健康研究|利培酮和阿立哌唑治疗学龄前儿童DBD和ADHD的临床研究

利培酮和阿立哌唑治疗学龄前儿童DBD和ADHD的临床研究

赵娜 程海燕 张娟 曲彩丽

中国妇幼健康研究2017,Vol.28Issue(3):285-288,4.
中国妇幼健康研究2017,Vol.28Issue(3):285-288,4.DOI:10.3969/j.issn.1673-5293.2017.03.021

利培酮和阿立哌唑治疗学龄前儿童DBD和ADHD的临床研究

Clinical study of risperidone and aripiprazole in treatment of preschool children with disruptive behavior disorder and attention deficit hyperactivity disorder

赵娜 1程海燕 1张娟 2曲彩丽3

作者信息

  • 1. 陕西中医药大学第二附属医院儿保科,陕西咸阳712000
  • 2. 咸阳市精神病专科医院精神科,陕西咸阳713200
  • 3. 上海市普陀区精神卫生中心,上海普陀200065
  • 折叠

摘要

Abstract

Objective To compare the efficiency and safety of risperidone and aripiprazole in treatment of preschool children with attention deficit hyperactivity disorder (ADHD) combined with disruptive behavior disorder (DBD).Methods Thirty-six 3 -6 year-old children diagnosed with ADHD combined with DBD were randomly divided to two groups with 18 cases in each .An 8-week treatment with risperidone or aripiprazole was given to different groups .Assessment was performed by Conners ' rating scale-revised and clinical global impression scale (CGI) before treatment and at end of week 2, 4, and 8 of treatment.Results Conners rating score did not have statistical differences between two groups in any stage of evaluation (P>0.05).After 2-week of treatment, scores of hyperactivity (risperidone group t=2.988, P <0.05; aripiprazole group t =2.682, P <0.05), impaired concentration (risperidone group t =2.988, P <0.05;aripiprazole group t=2.130, P<0.05), ADHD (risperidone group t=2.881, P<0.05; aripiprazole group t=3.756, P<0.05), oppositional defiant disorder (ODD) (risperidone group t=2.988, P<0.05; aripiprazole group t =2.247, P<0.05) and tolerance (risperidone group t=6.255, P<0.05;aripiprazole group t=5.889, P<0.05) in two groups decreased significantly compared to those of pre-treatment, and all differences had statistical significance .Indexes measured at fourth and eighth week of treatment in two groups had no statistically significant difference compared to those at second week of treatment (all P>0.05).Mean increase in weight and fasting blood sugar (FBS) in two groups at end point of treatment were both not significantly different from that before treatment (P>0.05). Increase of mean serum prolactin in risperidone group at end of treatment was higher than that in aripiprazole group , and the difference was statistically significant ( t =34.087, P <0.05).Conclusion Risperidone is similar to aripiprazole in reducing symptoms of ADHD combined with DBD with equal safety , but both drugs show high incidence of side effect .Clinical medication should be cautious .

关键词

利培酮/阿立哌唑/注意缺陷多动障碍/破坏性行为障碍

Key words

risperidone/aripiprazole/attention deficit hyperactivity disorder (ADHD)/disruptive behavior disorder (DBD)

分类

医药卫生

引用本文复制引用

赵娜,程海燕,张娟,曲彩丽..利培酮和阿立哌唑治疗学龄前儿童DBD和ADHD的临床研究[J].中国妇幼健康研究,2017,28(3):285-288,4.

中国妇幼健康研究

1673-5293

访问量2
|
下载量0
段落导航相关论文